Jingfeng Pharmaceutical(SZ:000908) Sou Hu Cai Jing·2025-07-08 08:25Company Overview - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with key products including various injections and capsules that are unique or under national medical insurance categories [2]. Financial Performance - In Q1 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.90 million yuan, reflecting a significant year-on-year decline of 960.04%. The gross profit margin stood at 66.62% [3]. Market Position - As of July 8, 2023, ST Jingfeng's stock closed at 5.99 yuan, with a rolling price-to-earnings (PE) ratio of 37.24 times, compared to the industry average PE of 54.20 times and a median of 32.89 times, placing the company at the 95th position within its industry [1][3]. - The total market capitalization of ST Jingfeng is 5.27 billion yuan [1]. Shareholder Information - As of March 31, 2025, the number of shareholders for ST Jingfeng was 34,311, a decrease of 6,228 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1].